Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

Global health targets

The end of AIDS as a global health threat: science-based or science fiction? - Side-event at the High Level Meeting on HIV/AIDS

Editor's pick
UN Web TV
8 June 2016
Populations

Advocacy brief for UN High Level Meeting says The Global Fund and key populations are delivering results

Editor's pick
Global Fund Observer
8 June 2016
Pregnancy and vertical transmission

Thailand is first country in Asia to eliminate mother-to-child transmission of HIV and syphilis

Editor's pick
UNAIDS
8 June 2016
African migrants

Sub-type C infection does not increase the risk of virologic failure when people are taking tenofovir-containing first-line ART

News
8 June 2016

HIV update - 8th June 2016

June 2016
HIV prevention policy

MPs Accuse Minister Of “Having Head In The Sand” Over HIV Prevention Drug

Editor's pick
BuzzFeed
7 June 2016
Human rights

UN High-Level Meeting on Ending AIDS faces battle over key populations

News
7 June 2016
Global health targets

High Level Meeting on Ending AIDS - Where’s the UK?

Editor's pick
Huffington Post
7 June 2016
Pregnancy and vertical transmission

Thailand Shows the Way Towards an HIV-Free World

Editor's pick
Inter Press Service
7 June 2016
Global health targets

Mayors of New York and Paris convene a global meeting of mayors on ending AIDS in cities

Editor's pick
UNAIDS
7 June 2016
Pharmaceutical industry

Gilead escapes liability in hepatitis C patent fight with Merck

Editor's pick
Reuters
7 June 2016
PrEP

NHS England must make 'revolutionary drugs that prevent HIV available immediately'

Editor's pick
Daily Mail
7 June 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
Epidemiology

Nearly 100 British troops have caught HIV, with more than 10000 STD cases since 2012

Editor's pick
Mirror.co.uk
7 June 2016
Global health targets

Men who have sex with men, sex workers groups ask: Will next UN political declaration on HIV and AIDS exclude most affected, least reached populations?

Editor's pick
Science Speaks
7 June 2016
Hepatitis C treatment

People from occupied territories receive Georgian citizenship for free Hepatitis C treatment

Editor's pick
Agenda.ge
7 June 2016
Hepatitis C treatment

Ele Hamburger: Medicaid programs should be taking “a long hard look” at their drug policies under state and federal law

Editor's pick
State of Reform
7 June 2016
PrEP

Stop stalling and make PrEP for HIV available now

Editor's pick
The BMJ
7 June 2016
Self-testing & home testing

HIV self-testing has several advantages, but some barriers to HIV testing likely to remain

News
7 June 2016
Hepatitis C treatment

Australia shows an alternative to rationing hepatitis C treatment

News
6 June 2016
Hepatitis C treatment

How to meet the first-ever global hepatitis targets

Editor's pick
International AIDS Society
6 June 2016
Harm reduction

Why Naloxone Should Be Accessible For Everyone

Editor's pick
Talking Drugs
6 June 2016
Human rights

No ending AIDS in Africa without protecting rights

Editor's pick
ARASA
6 June 2016
PrEP

HIV Charity Issues Legal Challenge To NHS For Refusing To Fund HIV Prevention Drug

Editor's pick
BuzzFeed
6 June 2016